Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Ayurcann Holdings Corp C.AYUR

Alternate Symbol(s):  AYURF

Ayurcann Holdings Corp. is a Canada-based cannabis extraction company. The Company is specialized in the processing and manufacturing of pharma grade cannabis and hemp for various derivative cannabis products. The Company, through its wholly owned subsidiary, Ayurcann Inc, is a licensed producer focused on providing cannabis products in verity of categories for the recreational and medical use... see more

Recent & Breaking News (CSE:AYUR)

AYURCANN TERMINATES BUSINESS COMBINATION

GlobeNewswire 13 hours ago

AYURCANN PROVIDES UPDATE ON BUSINESS COMBINATION

GlobeNewswire 1 day ago

AYURCANN REPORTS FISCAL YEAR 2024 RECORD SALES OF $45,265,235 IN GROSS REVENUE, FEATURING ANOTHER 100% YEAR-OVER-YEAR INCREASE

GlobeNewswire October 28, 2024

Canadian Investment Regulatory Organization Trade Resumption - AYUR

Canada NewsWire June 27, 2024

Ayurcann Holdings Corp is entering into a business combination with Arogo Capital Acquisition Corp. and its subsidiaries at a combined enterprise value estimated to be U.S. $210 million.

GlobeNewswire June 27, 2024

Canadian Investment Regulatory Organization Trading Halt - AYUR

Canada NewsWire June 27, 2024

AYURCANN REPORTS RECORD SALES IN Q3 2024 OF $11,655,360 FEATURING A 97% INCREASE IN GROSS REVENUE

GlobeNewswire May 27, 2024

AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE

GlobeNewswire February 28, 2024

Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs

GlobeNewswire January 5, 2024

AYURCANN ANNOUNCES AGSM RESULTS

GlobeNewswire December 22, 2023

AYURCANN REPORTS RECORD SALES IN Q1 2024 FEATURING A 249% INCREASE IN GROSS REVENUE

GlobeNewswire November 29, 2023

AYURCANN REPORTS 2023 FINANCIAL RESULTS FEATURING $22,371,604 IN GROSS REVENUE

GlobeNewswire October 30, 2023

AYURCANN HOLDINGS CORP. PROVIDES CORPORATE UPDATE, AND GROWTH STRATEGY

GlobeNewswire August 10, 2023

AYURCANN REPORTS RECORD SALES OF $5,893,351 FOR Q3 2023, AN INCREASE OF 114% OVER Q3 2022

GlobeNewswire May 29, 2023

AYURCANN REPORTS Q2 2023 FINANCIAL RESULTS FEATURING A 37% INCREASE IN YEAR-OVER-YEAR GROSS REVENUE

GlobeNewswire February 27, 2023

AYURCANN REPORTS Q1 2023 FINANCIAL RESULTS FEATURING A 80% INCREASE IN GROSS REVENUE

GlobeNewswire November 29, 2022

AYURCANN REPORTS 2022 FINANCIAL RESULTS FEATURING A 45.17% INCREASE IN GROSS REVENUE

GlobeNewswire October 28, 2022

AYURCANN HOLDINGS CORP. PROVIDES CORPORATE UPDATE

GlobeNewswire October 17, 2022

Ayurcann Holdings (CSE:AYUR) expands product offerings across Canada

John Ballem  October 4, 2022

Ayurcann Holdings Corp. Expands Product Offerings Across Canada

GlobeNewswire October 4, 2022